share_log

Mateon Therapeutics Inc | PRER14A: Preliminary revised proxy soliciting materials

SEC ·  Apr 17, 2020 15:43
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more